Table 4.
Characteristics of blaNDM−1 harbouring P. aeruginosa isolates
| Characteristics | Patient-1 | Patient-2 | Patient 3 |
|---|---|---|---|
| Isolate Number | P1 | P3 | P6 |
| Age(yr)/Sex | 57y/Female | 59y/Male | 30y/Female |
| Hospital location | ICU | ICU | ICU |
| Specimen source | Tracheal swab | Urine | Pus |
| Underlying disease/diagnosis | Sub-dural haemorrhage | Post stroke seizure | TB meningitis, transverse myelitis and communicating hydrocephalus |
| Co-morbid conditions | Diabetes& hypertension | Diabetes& hypertension | None |
| Antimicrobials used prior to detection of blaNDM−1 | Cefotaxime, gentamicin and ciprofloxacin | Flucloxacillin, meropenem and ciprofloxacin | Nitrofurantoin, ceftriaxone and flucloxacillin |
| Antibiotics tested | |||
| Amikacin | R | R | R |
| Gentamicin | R | R | R |
| Ciprofloxacin | R | R | R |
| Imipenem | R | R | R |
| Meropenem | R | R | R |
| Piperacillin | R | R | R |
| Piperacillin/tazobactam | R | R | R |
| Aztreonam | R | R | R |
| Ofloxacin | R | R | R |
| Levofloxacin | R | R | R |
| Ceftazidime | R | R | R |
| Cefepime | R | R | R |
| Colistin | S | S | S |